chemotherapy is begun one to two weeks after surgery. The standard regimen includes cisplatin or carboplatin + cyclophosphamide , or cisplatin + Taxol given intravenously every three to four weeks as tolerated for at least six cycles. Eighty percent of patients can be expected to respond. New studies using Taxol will in the near future determine whether Taxol should be used as the first-line treatment.
Over the past several years, a technique known as intraperitoneal (intra-abdominal) chemotherapy has been developed to deliver the chemotherapy directly into the abdominal cavity. This procedure requires surgery to place a port and its attached catheter beneath the skin. The catheter is brought
